Sign In

Ted Slafsky

Publisher and CEO of 340B Report and Founder and Principal of Wexford Solutions

Ted Slafsky is the Publisher and Chief Executive Officer of 340B Report, a subscription-based news service focused on covering developments in the federal 340B drug pricing program.13 He is a long-time healthcare thought leader and journalist with three decades of experience in 340B and journalism.1

Some key points about Ted Slafsky's background and career:

  1. He is the Founder & Principal of Wexford Solutions LLC, a consulting firm.15

  2. Slafsky began his career as an award-winning reporter and researcher at U.S. News & World Report.1

  3. He served in senior leadership for 22 years at 340B Health, a Washington D.C.-based association of over 1400 hospitals and health systems in the 340B program. He started as executive director and was later elevated to President & CEO.1

  4. During his tenure at 340B Health, he co-founded and led the 340B Coalition, an umbrella group of national organizations representing 340B providers.1

  5. Slafsky is recognized as a national expert and thought leader on healthcare access and prescription drug pricing.2

  6. He launched 340B Report in February 2020 as a new venture in addition to his role at Wexford Solutions.6

Ted Slafsky's LinkedIn profile can be found under the username ted-slafsky-12859793, where he shares insights and updates related to the 340B program and healthcare industry.24

Highlights

Sep 3 · linkedin

News Alert from 340B Report:

EMD Serono Extends 340B Contract Pharmacy Restrictions to All Covered Entities & Adds New Restrictions - https://lnkd.in/d-gt27Qb

To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg

#340B #pharmacy #drugpricing #hospitals #hospitalpharmacy

Aug 29 · linkedin

The latest from 340B Report:

Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal - https://lnkd.in/eAxjhP-g

Analysis Finds Growing Private Equity, Corporate Investments in 340B; Firm Conducting Study Fails to Mention Its Own PE Funding - https://lnkd.in/eXKTXnNe

Preparing for a Neutral 340B Claims Clearinghouse - https://lnkd.in/eF-qPUV2

State Contract Pharmacy Lawsuit Weekly Roundup: Judge Calls Astra Subpoenas ‘Overly Broad,’ Mo. Officials Push to Dismiss Lawsuit  - https://lnkd.in/euYbpbTx

Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions - https://lnkd.in/eun8DYMA

340B INDUSTRY LEADER SPOTLIGHT Christina Breckenridge, Senior Director of Client Success, RxStrategies - https://lnkd.in/eQtAF5p5

To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg

#340B #pharmacy #drugpricing #hospitals #hospitalpharmacy

Related Questions

What are Ted Slafsky's key achievements at 340B Health?
How did Ted Slafsky transition from journalism to healthcare leadership?
What is the significance of the 340B program in the healthcare industry?
How does Wexford Solutions contribute to the 340B Report?
What are Ted Slafsky's predictions for the future of the 340B program?
Ted Slafsky
Ted Slafsky, photo 1
Ted Slafsky, photo 2
Add to my network

Location

Washington, District of Columbia, United States